Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AWI | Common Stock | Options Exercise | $1.16M | +25.7K | +7.73% | $45.32 | 358K | Dec 27, 2022 | Direct | F1 |
transaction | AWI | Common Stock | Sale | -$1.77M | -25.7K | -7.17% | $68.83 | 332K | Dec 27, 2022 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | AWI | Stock Options (Right to Buy) | Options Exercise | $0 | -25.7K | -100% | $0.00* | 0 | Dec 27, 2022 | Common Stock | 25.7K | $45.32 | Direct | F3 |
Id | Content |
---|---|
F1 | Options exercised and shares sold pursuant to a 10b5-1 Plan adopted by the reporting person on June 8, 2022. Options exercised had a ten year exercise term limit and were scheduled to expire on February 20, 2023, as reflected in this Form 4. |
F2 | The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $68.405 to $69.12. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | The stock options were granted on February 20, 2013. Grant has a graded vesting schedule. Date exercisable will vary for each vesting tranche. All options are currently vested and exercisable. |